News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...
It argues that Pfizer and BioNtech's vaccine infringes patents Moderna filed between 2010 and 2016 for its messenger RNA or mRNA technology. All three companies' COVID-19 vaccines used mRNA ...
Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.
Reacting to reports that early phase 3 trials of Pfizer's Covid-19 vaccine have been 90% successful, Heidi Chow, pharmaceuticals campaigner at Global Justice Now said: "It's positive news that Pfizer ...
FILE - This Sept. 21, 2021 file photo shows vials of the Pfizer and Moderna COVID-19 vaccines in Jackson, Miss. Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech ...
Moderna sues Pfizer and BioNTech over coronavirus vaccine patent Lawsuit sets up clash between rival vaccine makers who used novel mRNA technology to battle covid August 26, 2022 More than 2 years ago ...
Moderna is suing Pfizer and BioNTech, alleging the companies copied its technology used to create their COVID-19 vaccine. The lawsuits were filed in Massachusetts and Germany.
FILE - This Sept. 21, 2021 file photo shows vials of the Pfizer and Moderna COVID-19 vaccines in Jackson, Miss. Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech ...
COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results